The GO2 Foundation together with other patient advocacy groups, has conducted a survey on the effect of COVID on lung cancer patients and recently participated in an expert panel event with Newswise.
Danielle Hicks, Chief Patient Officer at GO2 Foundation for Lung Cancer has been working in lung cancer non-profit for the past 11 years. She is responsible for all aspects of patient programming, services, engagement, and empowerment along with strategic insight and planning around lung cancer awareness and education. Through personal history with lung cancer, Bonnie Addario is her mother, she has had hands-on experience as a caregiver as it relates to lung cancer the disease, treatments, the emotional and physical experience along with experience through survivorship. She has developed multiple patient education programs and educational publications that have reach in 143 countries around the world. In her role, she directly touches patients, caregivers, physicians, nurses, and industry professionals. She attends scientific meetings specific to lung cancer, has sat on multiple advisory boards and has experience with speaking engagements across the lung cancer community.
“The good news in spite of all of this and even since the pandemic is that things are happening fast and furiously in the lung cancer space, so whether its new drug developments, new technologies for diagnostics, you name it – these things are happening and like I said it’s unfair to expect that a physician treating all these cancer types is going to be up to speed.”